Advances in the treatment of graft-versus-host disease

G. B. Vogelsang

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Graft-versus-host disease (GVHD) is a complicated disease whose treatment requires an equally multifaceted approach. Recipient conditioning, donor T cell activation, and end stage effecters all may be potential targets for treatment. Many drugs used in the past are returning to the forefront for investigation. Some of the newer nucleoside analogs that are in various stages of development, such as fludarabine and pentostatin, are showing promising activity in GVHD.

Original languageEnglish (US)
Pages (from-to)509-510
Number of pages2
Issue number3
StatePublished - 2000


  • Conditioning
  • GVHD
  • Treatment

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research


Dive into the research topics of 'Advances in the treatment of graft-versus-host disease'. Together they form a unique fingerprint.

Cite this